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Summary
BACKGROUND Maternal thyroid function during
early pregnancy is an important determinant of
early fetal brain development because the fetal thyroid
is unable to produce any T4 before 12–14 weeks’
gestation. Overt maternal hypothyroidism as seen in
severe iodine-deficient areas is associated with
severely impaired neurological development of the
offspring. At present, it is not known whether low
free T4 (fT4) levels during pregnancy in healthy
women from iodine sufficient areas may affect fetal
neurodevelopment.
METHODS Neurodevelopment was assessed at 10
months of age in a cohort of 220 healthy children,
born after uncomplicated pregnancies and deliveries,
using the Bayley Scales of Infant Development. Mater-
nal TSH, fT4 and TPO antibody status were assessed
at 12 and 32 weeks’ gestation. Maternal gestational
fT4 concentration was defined as an independent
parameter for child development.
RESULTS Children of women with fT4 levels below
the 5th ( <9·8 pmol/l, n ¼ 11) and 10th ( <10·4 pmol/l,
n ¼ 22) percentiles at 12 weeks’ gestation had signifi-
cantly lower scores on the Bayley Psychomotor
Developmental Index (PDI) scale at 10 months of
age, compared to children of mothers with higher
fT4 values ( t test, mean difference: 14·1, 95% con-
fidence interval (CI): 5·9–22 and 7·4, 95% CI: 1·1–13·9,
respectively). At 32 weeks’ gestation, no significant
differences were found. In the group of women with
the lowest 10th percentile fT4 concentrations at 12
weeks’ gestation, a positive correlation was found
between the mothers’ fT4 concentration and chil-
dren’s PDI scores (linear regression, R: 0·46,
P ¼ 0·03). After correction for confounding variables,
a fT4 concentration below the 10th percentile at 12
weeks’ gestation was a significant risk factor for
impaired psychomotor development (RR): 5·8, 95%
CI: 1·3–12·6).
CONCLUSIONS Low maternal plasma fT4 concentra-
tions during early pregnancy may be an important risk
factor for impaired infant development.
In pregnant women suffering from thyroid dysfunction,
decreased maternal fT4 levels play a critical role in the
neurological development of the fetus, especially during the
first trimester, since the fetus does not produce thyroid hormone
itself until 16–20 weeks’ gestation (Vulsmaet al., 1989;
Porterfield & Hendrich, 1993; Burrowet al., 1994; De Zegher
et al., 1995; Emerson, 1996; Fisher, 1996). Similarly, animal
and human studies have shown that impaired maternal thyroid
function during early gestation is associated with impaired fetal
neurological development, in contrast to maternal thyroid
dysfunction in late gestation (Morreale de Escobaret al., 1990;
Calvo et al., 1992; Contempreet al., 1993). To date, the
relationship between the thyroid hormone status of healthy
pregnant women and infant neurodevelopment has not been
investigated in iodine sufficient areas. In a recent study, no
relationship could be demonstrated between maternal plasma
fT4 levels at 32 weeks’ gestation and the infant’s neuro-
development at 5 years of age (Popet al., 1995). However, it
might be argued that it is the maternal plasma fT4 concentration
earlier in gestation which is important for fetal maturation and,
* See commentary on page 147.
Correspondence: Dr V. J. Pop, Associate Professor, Department of
Social and Behavioural Science, University of Tilburg, PO Box
90153, 5000 LE Tilburg, The Netherlands.
consequently, for infant development (Calvoet al., 1992;
Contempreet al., 1993). The present study overcomes these
limitations. Firstly, the maternal thyroid hormone status was
assessed in healthy women with no previous thyroid dysfunc-
tion, who experienced normal pregnancies and deliveries.
Secondly, in order to avoid possible bias on child development
from environmental factors (e.g. psycho-social aspects, dis-
eases), child development was assessed at an early age (10
months). Finally, the outcome of maternal fT4 levels at 12
weeks’ gestation on child development was compared with that
of fT4 levels at 32 weeks’ gestation.
Subjects and methods
Sample
The study was carried out in an iodine-sufficient area in the
south-east of the Netherlands, in and around the city of
Veldhoven (Rees-Wortelboeret al., 1987). Between January
and November 1994, 448 pregnant women (covering 80% of all
pregnancies within the region) who checked in for antenatal
assessment at four community midwife practices and at one
obstetric centre (St Joseph Hospital, Veldhoven) at 12 weeks’
gestation were invited to participate in a longitudinal study of
postpartum thyroid dysfunction. Women receiving antithyroid
drugs and/or thyroid hormones were excluded. The participants
were examined at 12 and 32 weeks’ gestation, four weeks’
postpartum, and at eight-week intervals thereafter until 36
weeks’ postpartum. The characteristics of the study group are
shown in Table 1.
Maternal thyroid determinants (fT4, TSH and TPO-Ab) were
assessed in early and late gestation and in the postpartum
period. Neonatal thyroid function was assessed on the fifth to
seventh postpartum days, as part of the Dutch national
screening program for congenital hypothyroidism. 310
Women (69%) consented to participate, 291 of them (94%)
completed the study. The women who did not participate did
not differ as far as age, parity and educational level were
concerned, 19 women were excluded, seven because of
spontaneous miscarriage (of whom 1 TPO-Abþ), one
women suffered from puerperal psychosis, nine had another
pregnancy within 6 months after delivery (of whom 1 TPO-Ab
þ), and two had moved outside the area. At ten months’
postpartum, 268 women were still eligible to be asked for
informed consent to evaluate their child’s neurodevelopment.
Of the 23 women excluded (2 with TPO-Abþ), three had
experienced neonatal deaths related to preterm birth, five had
had children with congenital abnormalities, and 15 women
had moved outside the area. Of the remaining 268 women, 244
(91%) consented to participate. Of these, a further 24 were
excluded for reasons of prematurity (4, of whom 1 had TPO-Ab
þ), severe neonatal asphyxia (4), twins (3), severe eclampsia
(2), intra-uterine growth retardation (2) and a birth weight of
<2500 g (9, of whom 1 had TPO-Abþ). Data analysis is based
on the remaining 220 women and their children, none of whom
had serious complications during pregnancy or delivery and the
details of whom are shown in Table 1. Permission for the study
was obtained from the Medical Ethics Committee of St Joseph
Hospital in Veldhoven.
Methods
Thyroid function. This was assessed by measuring the
concentrations of thyroid stimulating hormone (TSH, Kodak
Amerlite TSH-30, Ultrasensitive Assay, Kodak Clinical
Diagnostics Ltd, Amersham, UK), free thyroxine (fT4, Kodak
Amerlite MAB FT4 Assay), and thyroid peroxidase antibodies
(TPO-Ab, Immunometric Enzyme, Combikit, Orgentec
GMBH, Mainz, Germany). Evaluation of the assays throughout
the study showed interassay coefficients of variation for TSH of
20%, 4·8%, 6·3% and 5·1% at concentrations of 0·04, 0·68, 8·2
and 29·2 mU/l, respectively, for fT4 of 11·1%, 11·3% and
12·2% at concentrations of 6·1, 19·3, and 27·7 pmol/l,
respectively, and for a TPO-Ab of 18% and 8·5% at
concentrations of 18 and 100 IU/ml, respectively.
Child neurodevelopment. This was assessed by means of the
Dutch version of the Bayley Scales of Infant Development
(Bayley, 1969). The Mental Development Index (MDI) scale of
the Bayley test evaluates aspects of functioning such as eye-
hand coordination, manipulation, understanding of object
relations, imitation, and early language development. The
Psychomotor Developmental Index (PDI) scale assesses gross
motor development. The Dutch Bayley scales (Van der Meulen
& Smrkovsky, 1983) have a mean of 100 and a standard
deviation of 16 (these are still considered reliable). All children
were visited at home by one developmental psychologist who
was blind to the thyroid hormone and TPO-Ab status of the
mother during pregnancy.
Several confounding variables which have been reported in
the literature to be related to child neurodevelopment were
assessed such as: maternal depression (using Research
Diagnostic Criteria, RDC) (Spitzeret al., 1978), psycho-
social factors, demographic features, life-style habits
during pregnancy (smoking, alcohol), breastfeeding and the
occurrence of stressful life events.
Statistical analysis. Statistical analyses were performed using
the Statistical Package of Social Science (SPSS). Statistical
testing was by Student’st test, linear regression and logistic
regression analysis. In the logistic regression analysis, and
unadjusted model with low scores on the Bayley Scales (below
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1 SD of the mean,<84) was used as the dependent variable. The
independent variables were entered into the regression at a
univariate level in order to assess significant independent
associations with the Bayley scores and, subsequently, at a
multivariate level, to control for confounding effects regarding
the association between maternal fT4 and these scores.
Results
Figure 1 shows the childrens’ scores on the two Bayley
subscales in relation to the maternal plasma fT4 concentrations
at 12 weeks’ gestation. The scores on the Psychomotor
Development Index (PDI) of children of mothers with
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Table 1 Characteristics of the study group.
Group A B C
Number of women 291 71 220
Educational level (%)
Basic school 0·7 1·3 1·0
Low college degree 22·1 27·1 20·2
High college degree 53·0 45·4 55·4
Graduated/academic 24·2 26·2 23·4
Mean age of women, years (SD) 29·6 (3·2) 29·4 (3·2) 29·5 (3·1)
Parity
Primipara 105 (36) 27 (38) 78 (35)
Multipara 186 (64) 40 (62) 142 (65)
Smoking habits:
Never 165 (57) 38 (54) 127 (58)
No smoking in pregnancy 80 (28) 22 (31) 58 (26)
Smoked in pregnancy 46 (16) 11 (15) 35 (16)
Alcohol intake:
Never 90 (31) 22 (31) 68 (31)
No intake in pregnancy 151 (51) 32 (46) 119 (54)
Intake in pregnancy 50 (17) 17 (23) 33 (15)
Mean birth weight, g (SD) 3441 (579) 3386 (624) 3471 (550)
Sex
No of girls (%) 129 (44) 34 (47) 99 (45)
No of boys (%) 162 (56) 37 (53) 121 (55)
No. of women breastfeeding* (%) 200 (69) 40 (57) 160 (73)
Mean fT4 concentrations, pmol/l (SD)
12 weeks’ gestation 13·2 (2·5) 13·6 (2·7) 13·1 (2·6)
32 weeks’ gestation 10·4 (1·9) 10·8 (2·0) 10·4 (1·8)
No. with TPO-Ab (%)
12 weeks’ gestation
>50 U/ml 29 (10) 5 (7) 24 (11)
> 100 U/ml 18 (6·2) 3 (4) 15 (7)
32 weeks’ gestation
>50 U/ml 15 (5) 2 (3) 13 (6)
>100 U/ml 8 (3) 2 (3) 6 (3)
No. with postpartum thyroid
dysfunction (%) 15 (5) 2 (3) 13 (6)
No. with depression (%)
during pregnancy 70 (24) 19 (26) 51 (23)
during postpartum 110 (38) 29 (40) 81 (37)
A, characteristics of the women in the original sample, (n¼ 291); B, characteristics of the women
not included in the follow up (n¼ 71); C, characteristics of the women in the follow-up study
(n¼ 220). *: breastfeeding: at least four weeks’ of exclusive breastfeeding.
fT4 concentrations in the lowest 5th and 10th percentiles at 12
weeks’ gestation were significantly lower than the scores of the
remainder of the group (mean difference: 14·1, 95% CI: 5·9–
22·3, and 7·4, 95% CI: 1·1–13·9, respectively). At 32 weeks’
gestation, no differences in scores could be demonstrated
between any of the subgroups (data not shown). Similarly,
children of mothers with fT4 concentrations in the lowest fT4
5th and 10th percentiles had lower scores on the Mental
Development Index subscale (MDI), although these differences
were not significant. Therefore, the PDI scores were studied
more closely.
Figure 2 presents a scatter diagram of the group of women
with the lowest 10th percentile plasma fT4 concentrations at 12
weeks’ gestation and correlates maternal fT4 concentrations
with their children’s scores on the Psychomotor Developmental
Index scale (PDI). From this, it can be seen that, the lower the
mother’s fT4 concentration, the lower the child’s score (linear
regression, R: 0·46,P¼ 0·03). All children who were assessed
at 10 months of age had T4 and TSH values within the normal
range by approximately one week after birth, as assessed by the
national screening programme for congenital hypothyroidism
(data not shown).
In Table 2, the maternal fT4 and TSH status during
pregnancy is shown in relation to the TPO-Ab titers. The
three women with elevated TSH levels at 32 weeks’ gestation
had a TSH of 2·7, 3·2 and 7·1 mU/l with a fT4 of 8·3, 8·7 and
8·0 pmol/l respectively. At 12 weeks’ gestation, 6/24 women
(25%) with TPO-Ab>50 U/ml had fT4 levels<10th percentile,
compared to 16/196 (8%) of the TPO-Ab negative women. This
means that the RR of women with TPO-Ab titers>50 mU/l at
12 weeks’ gestation for fT4>10th percentile at 12 weeks’
gestation is 3·1 (95% CI: 1·3–7·1). Subsequently (maternal fT4
levels at 32 weeks’ gestation not being related to child
outcome), we looked at the relation between elevated TPO-
Ab titres at 32 weeks’ gestation and fT4 levels at 12 weeks’
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Fig. 1 Differences in mean scores on the two Bayley subscales
comparing different percentiles of fT4 at 12 weeks’ gestation (t test).
a, Lowest 5th percentile (<9·8 pmol/ln¼ 11A) versus remaining
group (n¼ 209B). *mean difference: 14·1 (95% CI: 5·9¹ 22·3). b,
Lowest 10th percentile (<10·4 pmol/l,n¼ 22A) versus remaining
group (n¼ 198B). **mean difference: 7·4 (95% CI: 1·1¹ 13·9). c,
Lowest 15th percentile (<10·9 pmol/l,n¼ 34A) versus remaining
group (n¼ 186B). d, Lowest 20th percentile (<11·4 pmol/l,n¼ 45



























































Fig. 2 Scatter diagram correlating the scores on the Psycho-Motor
Developmental Index Scale of children of women with the lowest
10th percentile fT4 concentrations at 12 weeks’ gestation
(<10·4 pmol/l,n¼ 22).
gestation. Of the 13 women with TPO-Ab titres>50 mU/l at 32
weeks’ gestation, 6 (46%) had fT4 levels<10th percentile at 12
weeks’ gestation whereas of the 207 TPO-Ab negative women
at 32 weeks’ gestation only 16 (8%) had fT4 levels<10th
percentile at 12 weeks’ gestation. The RR therefore of women
with elevated TPO-Ab titres at 32 weeks’ gestation for low fT4
levels at 12 weeks’ gestation is 6·0 (95% CI: 2·8–12·7).
Table 3a shows the results of the independent associations
between several maternal variables and the low PDI scores of
the children. Alcohol use, maternal TPO-Ab status during
pregnancy, fT4 in the lowest 10th percentile (<10·4 pmol/l) at
12 weeks’ gestation, gestational depression, low educational
level of the mother, and the occurrence of a negative life event,
were all significantly associated with a low PDI score. An fT4
concentration at 32 weeks’ gestation in the range of the lowest
10th percentile (<8·5 pmol/l) was not related to a low PDI score.
In order to correct the fT4 effect on the PDI scores for possible
confounders of infant development, a multiple logistic regres-
sion analysis was carried out (Table 3b) with the PDI score as
the dependent variable. An fT4 concentration in the range of the
lowest 10th percentile (<10·4 pmol/l) at 12 weeks’ gestation,
alcohol intake by the mother during pregnancy, maternal
depression during pregnancy, and the occurrence of negative
life events (as rated by the mother), were all significantly
related to a low score (below 1 SD of the mean) on the PDI
scale. Again, fT4 concentrations in the range of the lowest 10th
percentile (<8·4 pmol/l) at 32 weeks’ gestation were not related
to impaired psychomotor development, neither were high titres
of TPO-Ab during pregnancy.
Discussion
This is the first study to show that low material fT4
concentrations in apparently healthy women during early
gestation implicate a significantly increased risk (RR 5·8) of
impaired neurodevelopment in the infant.
Animal studies have shown that thyroid hormone is a major
importance to early fetal cerebral development, possibly due to
its direct effect on the development of the cerebral T3 nuclear
receptor (Brent, 1994). Moreover, animal studies have shown
that during early pregnancy, the fetus is totally dependent on
maternal fT4 concentration, since it is unable to produce
thyroid hormone (Calvoet al., 1992). In humans, clinical
studies have shown that fetal and/or neonatal thyroid hormone
deficiency, due to congenital hypothyroidism or iodine
deficiency, has a dramatic negative impact on cerebral
development (Contempret al., 1993; Delange, 1996; Foley,
1996; de Vijlder & Vulsma, 1996). Moreover, premature
neonates show psychomotor retardation associated with low
postnatal thyroxine concentrations (Den Oudenet al., 1996;
Reus et al., 1996; Vulsma & Kok, 1996). These are all
examples of mothers and infants with serious health problems.
In contrast, this study questioned whether low normal plasma
fT4 concentrations during pregnancy in healthy women with no
previous thyroid dysfunction guarantees an adequate thyroid
hormone status for the fetus, and we hypothesised that there
might be differences in the individual thyroxine requirements
of mother and child. During the first trimester of normal
pregnancy there is an increase of fT3 and fT4 with a moderate
suppression of TSH, both related to the increase in hCG levels
(Burrow et al. 1994). Moreover, total T4 and T3 levels are
increased throughout pregnancy, due to an increase in serum
thyroxine binding globulin. The increase in fT4 and fT3 during
early pregnancy seems to be highly relevant for the fetus which
produces no thyroxine during this stage of gestation. It might be
hypothesised that women with low levels of fT4 during early
gestation, which seems to be without any consequences for a
normal physiological pregnancy, are at risk of sub-optimal
levels of fT4 for the fetus. Since fetal development is
completely dependent on the maternal thyroid hormone
supply, we measured fT4 at 12 weeks’ gestation. The regression
line in Figure 2 suggests (although the correlation is rather low)
that, within the lower range (10th percentile) of maternal fT4
concentrations during early pregnancy, the young child’s
psychomotor development is directly related to the maternal
thyroid hormone status. In contrast, after the first trimester of
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Table 2 fT4 and TSH concentrations in relation to TPO-Ab titres of
220 women at 12 and 32 weeks’ gestation.
12 weeks gestation 32 weeks gestation
N N
A. fT4 (10th percentile) 10·4 pmol/l 8·5 pmol/l
fT4 < 10th percentile 22 22
TPO-Ab>50 U/ml 6 7
TPO-Ab> 100 U/ml 5 2
fT4 >10th percentile 198 198
TPO-Ab>50 U/ml 18 6
TPO-Ab> 100 U/ml 10 4
B. TSH
TSH<0·14 U/ml 10 4
TPO-Ab>50 U/ml 2 0
TPO-Ab>100 U/ml 1 0
TSH>2·2 mU/l 4 3
TPO-Ab>50 U/ml 2 0
TPO-Ab>100 U/ml 2 0
Reference range for fT4: 8·8–18 pmol/l. Reference range for TSH:
0·14–2·2 mU/l.
pregnancy, if there is sufficient iodine intake, the increasing
fetal thyroid hormone production gradually becomes respon-
sible for fetal growth and development (Calvoet al., 1992;
Contempreet al., 1993). Indeed, at 32 weeks’ gestation, low
maternal fT4 concentrations were not correlated with impaired
development. In a previous study, a significant relation has been
demonstrated between maternal TPO-Ab levels at 32 week’s
gestation and impaired child development at the age of 4·5
years: a reduction in IQ of 10 points (Popet al., 1995). A reason
for this finding was unclear: TPO-Ab are supposed to be an
epiphenomenon of auto-immune disease rather than a direct
‘harmful agent’. However, the present study might provide an
explanation for the previous finding: women with elevated
titres of TPO-Ab at 32 week’s gestation are at particular risk
(RR: 6, 95% CI: 2·8–12·7) of low fT4 levels during early
gestation.
What is the clinical relevance of a statistically significant
impaired score on the PDI scale in children of mothers with
low fT4 during early gestation? A difference of 10 points on the
psychomotor developmental index score reflects a delay of
one month in the development of the retarded group (Bayley,
1969). Although the impact of this delay might be barely
perceptible at the age of 10 months, the consequences will be
important if the difference persists in later life. While it may be
argued that child neurodevelopment on the Bayley Scales is
more reliable if the child is assessed at 18–24 months of age,
the literature on prematurity (33 weeks’ gestation) and the
outcome following prenatal complications show that results
from assessments at as early as six months of age are able to
predict the later outcome (Siegel, 1982; Van Baar & De Graaff,
1994; Van Wassenaert al., 1997). The children in the present
study were all born after pregnancies and deliveries with no
serious complications, and were free of any explicit abnorm-
alities during the first postpartum year. In order to evaluate
whether there is an association between child development and
a prenatal factor in a cohort of children in whom a barely
perceptible difference could be expected, the investigation
should be carried out as early as possible (for example, during a
neonatal examination). The clinical implications of these
findings could be impressive. If children of women from the
general population in iodine-sufficient areas, with fT4 con-
centrations in the lowest 5th to 10th percentiles during early
gestation, are more likely to have impaired neuro-development,
the question arises as to whether this impairment could be
prevented by the administration of thyroxine to pregnant
women with low fT4 levels. The implications of this
supplementation for the offspring of women from iodine-
deficient areas could be even greater. From this study, one
preliminary conclusion could be that maternal fT4 values in the
low normal range during early pregnancy are associated with
impaired child development and that women with high TPO-Ab
titres are particular at risk. further research is needed to
determine whether these borderline’ concentrations of maternal
fT4 can any longer be accepted as ‘normal’, with regard to
infant development.
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Table 3 Logistic regression analysis, (method enter,n¼ 220)
dependent variable: low score of the Psychomotor Scale (PDI) of the
Bayley Scale of Infant Development. (SD¼ 16, Mean¼ 100). Low




Smoking during gestation 1·7 0·6–5·2
Obstetric factors 1·2 0·6–2·9
Alcohol use during pregnancy 3·0 1·4–6·6
TPO-Ab> 100 U/ml at 12 weeks’ gestation 3·8 1·3–10·2
TPO-Ab> 100 U/ml at 32 weeks’ gestation 2·9 0·6–13·8
fT4 of lowest 10th percentile at 12 wks gest 3·6 1·1–12·1




Gestational depression 3·1 1·3–6·3
Postpartum depression 1·4 0·8–2·7
Postpartum major depression 1·3 0·4–4·0
Depression in parents 1·0 0·5–1·9
Demographic features
Marital state 1·9 0·7–5·4
Low educational level 1·8 1·1–2·9
Previous episode of depression 1·5 0·7–3·2
Occurrence of negative life events 1·9 1·1–3·7
Work outside home 1·9 0·8–3·8
B. Multiple regression
Pregnancy-related factors
Smoking during gestation 1·2 0·5–2·8
Obstetric factors 1·2 0·6–2·9
Alcohol use during pregnancy 3·3 1·3–8·7
TPO-Ab> 100 U/ml at 12 weeks’ gestation 3·4 0·3–14·0
TPO-Ab> 100 U/ml at 32 weeks’ gestation 2·7 0·2–42·0
fT4 of lowest 10th percentile at 12 wks’ gest 5·8 1·3–12·6




Gestational depression 3·3 1·1–10·3
Postpartum depression 1·9 0·8–4·6
Postpartum major depression 2·5 0·3–16·2
Depression in parents 2·3 0·9–5·7
Demographic features
Marital state 1·1 0·4–6·2
Low educational level 2·0 1·1–4·8
Previous episode of depression 3·1 0·9–9·5
Occurrence of negative life events 2·6 1·1–6·1
Work outside home 1·9 0·6–4·6
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